IDL-2965 Oral Capsule
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Indalo Therapeutics, Inc.
Overview
IDL-2965 Oral Capsule is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
IDL-2965 Oral Capsule clinical trials
Explore related
Medical disclaimer. This page summarizes research about IDL-2965 Oral Capsule for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.